- Home
- IMMP vs ELMD Comparison
IMMP vs ELMD Comparison
Compare IMMP & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- ELMD
- Stock Information
- Founded
- IMMP 1987
- ELMD 1992
- Country
- IMMP Australia
- ELMD United States
- Employees
- IMMP N/A
- ELMD N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IMMP Health Care
- ELMD Health Care
- Exchange
- IMMP Nasdaq
- ELMD Nasdaq
- Market Cap
- IMMP 251.8M
- ELMD 206.5M
- IPO Year
- IMMP N/A
- ELMD 2010
- Fundamental
- Price
- IMMP $1.68
- ELMD $24.84
- Analyst Decision
- IMMP Buy
- ELMD Strong Buy
- Analyst Count
- IMMP 1
- ELMD 2
- Target Price
- IMMP $7.00
- ELMD $35.50
- AVG Volume (30 Days)
- IMMP 88.5K
- ELMD 103.0K
- Earning Date
- IMMP 10-21-2025
- ELMD 11-11-2025
- Dividend Yield
- IMMP N/A
- ELMD N/A
- EPS Growth
- IMMP N/A
- ELMD 46.55
- EPS
- IMMP N/A
- ELMD 0.85
- Revenue
- IMMP $3,306,742.00
- ELMD $64,000,000.00
- Revenue This Year
- IMMP N/A
- ELMD $14.47
- Revenue Next Year
- IMMP $725.37
- ELMD $10.33
- P/E Ratio
- IMMP N/A
- ELMD $28.80
- Revenue Growth
- IMMP 31.28
- ELMD 16.97
- 52 Week Low
- IMMP $1.32
- ELMD $17.73
- 52 Week High
- IMMP $2.71
- ELMD $35.56
- Technical
- Relative Strength Index (RSI)
- IMMP 50.03
- ELMD 59.06
- Support Level
- IMMP $1.60
- ELMD $23.98
- Resistance Level
- IMMP $1.76
- ELMD $24.92
- Average True Range (ATR)
- IMMP 0.06
- ELMD 1.13
- MACD
- IMMP 0.01
- ELMD -0.11
- Stochastic Oscillator
- IMMP 52.94
- ELMD 41.38
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.